Related by context. All words. (Click for frequent words.) 75 metastatic colorectal 75 biliary tract cancer 74 relapsing remitting MS RRMS 73 CYT# potent vascular disrupting 73 AA Amyloidosis 73 metastatic gastric 72 recurrent glioblastoma multiforme 72 pediatric malignancies 72 kidney urologic 71 AA amyloidosis 71 malignant pleural mesothelioma 71 recurrent NSCLC 71 nonsmall cell lung cancer 71 metastatic bladder 71 gefitinib Iressa 71 ZACTIMA 71 Ozarelix 71 IL# PE#QQR 71 Glioblastoma Multiforme GBM 70 trastuzumab DM1 T DM1 70 recurrent metastatic 70 non metastatic osteosarcoma 70 metastatic neuroendocrine tumors 70 metastatic renal 70 metastatic malignant 70 superficial bladder cancer 70 metastatic RCC 70 haematologic 70 YONDELIS 70 Bayer HealthCare Onyx Pharmaceuticals 70 Eculizumab 70 complement inhibitor eculizumab 70 myelofibrosis polycythemia vera 70 Immunotherapeutic 70 metastatic GIST 70 BRIM2 70 papillary renal cell carcinoma 69 thalidomide Thalomid 69 Renal Cell Carcinoma RCC 69 recurrent glioblastoma multiforme GBM 69 Metastatic breast cancer 69 docetaxel Taxotere ® 69 pancreatic carcinoma 69 Golimumab 69 Myelodysplastic Syndrome 69 Malignant Melanoma 69 IV NSCLC 69 LHRH receptor positive 69 Anthracycline 69 ACTEMRA TM 69 stage IIIB 69 Lupus Nephritis 69 Hepatocellular Carcinoma 69 Alemtuzumab 69 Velcade bortezomib 69 Degarelix 69 hypervascular tumors 69 Proxinium TM 69 relapsed MM 69 Mitomycin C 69 hepatocellular cancer 69 Diabetic Macular Edema 69 SHPT 69 AEG# 69 invasive candidiasis 69 differentiated thyroid 69 lenalidomide Revlimid R 69 BR.# 69 MGd 69 Advanced Renal Cell 69 Amrubicin 69 Dasatinib 69 Advanced Melanoma 69 Squamous 69 Temsirolimus 69 ThermoDox R 69 Deforolimus 69 Hodgkin lymphoma HL 69 bronchogenic carcinoma 69 huC# DM4 68 pancreatic adenocarcinoma 68 smoldering myeloma 68 eosinophilic asthma 68 Cloretazine 68 cisplatin resistant 68 Myelodysplastic Syndrome MDS 68 non squamous NSCLC 68 Decitabine 68 neuroendocrine cancers 68 Glufosfamide 68 AGILECT R 68 Fludara ® 68 receptor tyrosine kinase inhibitor 68 carcinoid tumors 68 Glioblastoma Multiforme 68 MAGE A3 ASCI 68 leukemia AML 68 thoracoscopic lobectomy 68 ADVEXIN therapy 68 Waldenstrom macroglobulinemia 68 Rilonacept 68 relapsed leukemia 68 mertansine 68 Cutaneous T 68 candidemia 68 GRN# 68 phase IIb study 68 Vandetanib 68 vismodegib 68 metastatic renal cell 68 forodesine 68 Kit CD# positive 68 assessing T DM1 68 p# biomarker 68 budesonide foam 68 Fabry Disease 68 Gliadel Wafer 68 psoriatic arthritis PsA 68 Atypical Hemolytic Uremic Syndrome 68 SUTENT ® 68 pancreatic NET 68 prospective randomized placebo 68 Dupuytren Contracture 68 commercialize deforolimus 68 including eniluracil ADH 68 EXJADE 68 phase IIb clinical 68 ZOLINZA 68 pain palliation 68 chronic thromboembolic pulmonary 68 advanced medullary thyroid 68 evaluating tivozanib 68 recurrent glioblastoma 68 epithelial ovarian 68 benign prostatic hypertrophy BPH 68 proliferative diabetic retinopathy 68 Leukemias 68 proliferative retinopathy 67 unresectable tumors 67 Cabazitaxel 67 ospemifene 67 CTAP# Capsules 67 galiximab 67 Chronic lymphocytic leukemia 67 urothelial cancer 67 advanced unresectable 67 medically inoperable 67 GRNOPC1 contains 67 Xanafide 67 Gleevec resistant 67 Metastatic Prostate Cancer 67 Xelox 67 diabetic retinopathy DR 67 Enzyme Replacement Therapy 67 FOLOTYN ® 67 Nexavar sorafenib 67 ductal carcinomas 67 STRIDE PD 67 mRCC 67 Soft Tissue Sarcoma 67 Renal Cell Carcinoma 67 metastatic lung cancer 67 Severe Sepsis 67 hepatocellular carcinoma HCC 67 smoldering multiple myeloma 67 terlipressin 67 paclitaxel poliglumex 67 either acutely decompensated 67 GW# [003] 67 Daclizumab 67 epithelial tumors 67 pertuzumab 67 Leber Hereditary Optic Neuropathy 67 sorafenib tablets 67 Microplasmin 67 SNT MC# 67 fallopian tube carcinoma 67 gastrointestinal stromal tumors GIST 67 Aviptadil 67 Aflibercept 67 Naive Patients 67 Chronic Myelogenous Leukemia CML 67 CBLC# 67 radiolabeled TM# 67 carcinoma HCC 67 IMA# 67 Tavocept 67 AVOREN 67 unresectable stage 67 relapsed ALL 67 nonmetastatic 67 Vidaza azacitidine 67 CEQ# 67 sunitinib Sutent 67 TTF Therapy 67 diarrhea predominant irritable 67 refractory acute myeloid 67 squamous cell lung cancer 67 TYZEKA 67 advanced hepatocellular carcinoma 67 HuMax EGFr 67 Cimzia TM 67 Surgical resection 67 double blinded placebo 67 concurrent chemoradiation 67 nonmelanoma skin cancers 67 liver resection 67 phase IIb trial 67 Zevalin consolidation 67 pediatric acute lymphoblastic 67 riociguat 67 randomized Phase IIb 67 Safinamide 67 BrachySil TM 67 Sym# 67 Proellex TM 67 Malignant Glioma 67 Adjuvant chemotherapy 67 pelvic malignancies 67 basal cell carcinoma BCC 67 Kepivance 67 TELINTRA 67 antibody MAb 67 chemoradiotherapy 67 intravesical infusion therapy 67 Chronic Lymphocytic Leukemia CLL 67 metastatic pancreatic 67 HER2 overexpression 67 recurrent metastatic ovarian cancer 67 canakinumab 67 novel VDA molecule 67 leukemia ALL 67 acetonide FA 67 malignant ascites 67 ImmunoVEX HSV2 67 Certolizumab pegol 67 lapatinib Tykerb 67 EGFR TKI 67 vWD 67 neoadjuvant therapy 67 Elotuzumab 67 chronic ITP patients 67 tolevamer 67 TACI Ig 67 ToGA 67 Relapsed Multiple Myeloma 67 Adenomas 67 colorectal liver metastases 67 PrevOnco 67 GIST tumors 67 Severe VOD 67 non resectable metastatic 67 opioid induced bowel dysfunction 67 esophageal candidiasis 66 ALK inhibitors 66 triphendiol 66 Gemzar ® 66 prostate carcinomas 66 squamous cell carcinoma SCC 66 urothelial carcinoma 66 pancreatic neuroendocrine tumors 66 Hedgehog Pathway Inhibitor 66 Lung transplantation 66 non squamous 66 oral ridaforolimus 66 systemic fungal infections 66 Pivotal Clinical Trial 66 HQK 66 myelofibrosis MF 66 Benign Prostatic Hyperplasia BPH 66 hypereosinophilic syndrome 66 cervical carcinoma 66 alvespimycin 66 prospective multicenter study 66 TORISEL 66 PAOD 66 investigational monoclonal antibody 66 HER2 positive metastatic breast 66 BRIM3 66 metastatic malignant melanoma 66 MYLOTARG 66 Stereotactic Body Radiation Therapy 66 neratinib 66 efaproxiral 66 Papillary 66 allogeneic HSCT 66 metastatic renal cell carcinoma 66 Arranon 66 Personalized Immunotherapy 66 lupus nephritis 66 NeuroStar TMS Therapy 66 constipation OIC 66 Intravenous immunoglobulin 66 Azacitidine 66 myeloproliferative diseases 66 chemotherapy cisplatin 66 anti angiogenic therapy 66 palliative radiotherapy 66 Idiopathic Pulmonary Fibrosis 66 Tesmilifene 66 invasive aspergillosis 66 recurrent glioma 66 dirucotide MBP# 66 erlotinib Tarceva 66 colorectal cancer liver metastases 66 Patients Treated With 66 TTR amyloidosis 66 INCB# [001] 66 stage IIIA 66 endometrial hyperplasia 66 gastrointestinal stromal tumors GISTs 66 polycythemia vera PV 66 LHON 66 OMNARIS HFA 66 minimally symptomatic 66 idiopathic pulmonary fibrosis IPF 66 investigational therapies 66 BEXXAR Therapeutic Regimen 66 thromboembolic disease 66 Vascugel ® 66 stage IIIB IV 66 Gastrointestinal Stromal Tumors 66 OncoVEX GM CSF 66 Hematologic 66 liver metastases 66 atypical Hemolytic Uremic Syndrome 66 BRAF inhibitor 66 BCG refractory carcinoma 66 Pazopanib 66 Cariprazine 66 renal carcinoma 66 cilengitide 66 postoperative ileus 66 cutaneous squamous cell carcinoma 66 adjuvant radiotherapy 66 gastrointestinal GI cancers 66 adult chronic ITP 66 polycythemia vera essential thrombocythemia 66 Azedra 66 myeloproliferative disorders 66 multiple myeloma MM 66 portal vein thrombosis 66 RhuDex ® 66 Tarceva TM 66 anterior uveitis 66 tumors GIST 66 localized prostate 66 SUTENT 66 midstage clinical 66 secondary hyperparathyroidism 66 untreated metastatic melanoma 66 Trastuzumab 66 Phase III Pivotal 66 prospective randomized multicenter 66 Spectranetics laser 66 hepatorenal syndrome 66 overactive bladder syndrome 66 TLK# 66 Hydroxyurea 66 Hurthle cell 66 colorectal lung 66 Follicular Lymphoma 66 Phase Ib II 66 LEUKINE 66 NAVISTAR R 66 TOCOSOL Camptothecin 66 diabetic kidney 66 EFAPROXYN 66 Combination REOLYSIN R 66 multicenter Phase II 66 Epratuzumab 66 pemphigus vulgaris 66 Cardiotoxicity 66 eprotirome 66 Radiofrequency ablation 66 peritoneal carcinomatosis 66 Mucositis 66 vemurafenib 66 eosinophilic pneumonia 66 PSMA ADC 66 transthyretin amyloidosis 66 herpetic keratitis 66 Vascugel 66 Fibrillex TM 66 gastrointestinal stromal tumor GIST 66 Cx# [002] 66 locoregional 66 CIMZIA ™ 66 hormone LHRH antagonist 66 liver metastasis 66 Toxicities 66 TMS Therapy 66 Ophena TM 66 depsipeptide 66 Elagolix 66 cetuximab Erbitux 66 erlotinib Tarceva ® 66 Diabetic Neuropathy 66 Bezielle 66 Dacogen injection 66 prostate adenocarcinoma 66 LymphoStat B TM 66 Neulasta ® 66 Sudhir Agrawal D.Phil 66 Enzastaurin 66 ARIXTRA R 66 hyperphenylalaninemia HPA due 66 BRAF V#E mutation 66 Neovascular AMD 66 sorafenib Nexavar 66 cediranib 66 Natalizumab 66 Vicinium TM 66 EOquin TM phase 66 myelodysplastic myeloproliferative diseases 66 Meningiomas 66 acadesine 66 HeFH 65 benign prostatic hyperplasia enlarged 65 Pemetrexed 65 Navelbine ® 65 EchoCRT 65 primary hyperparathyroidism 65 Allovectin 7 65 efalizumab 65 hematologic disorders 65 antiangiogenic therapy 65 MALT lymphoma 65 R sorafenib tablets 65 refractory metastatic colorectal cancer 65 pulmonary hypertension PH 65 Myelodysplastic syndromes MDS 65 Canvaxin 65 R lenalidomide 65 Investigational Treatment 65 Motesanib 65 Glioblastoma multiforme GBM 65 NOMID 65 Metastatic Melanoma 65 monoclonal antibody conjugated 65 Dacogen decitabine 65 Glioblastoma multiforme 65 cytoreduction 65 Torisel 65 opioid induced constipation OIC 65 Fx #A 65 CMV reactivation 65 HepaSphere 65 prostate cancer CaP 65 hyperplasia BPH 65 prostate carcinoma 65 Antitumor Activity 65 osteosarcomas 65 RSD# oral 65 systemic anaplastic large 65 myelodysplastic syndrome MDS 65 refractory metastatic 65 malignant neoplasms 65 evaluating T DM1 65 elacytarabine 65 Zolinza 65 refractory gout 65 gastrointestinal stromal tumor 65 Phase #b/#a clinical 65 seminoma 65 Metastases 65 Hypotension 65 OHR/AVR# 65 clinically localized prostate 65 vinca alkaloid 65 metastatic kidney 65 choroidal neovascularization 65 cMET 65 gallium nitrate 65 trastuzumab DM1 65 Accelerated Partial Breast Irradiation 65 Pirfenidone 65 Epidermal Growth Factor Receptor 65 rituximab Rituxan 65 carcinoid 65 Hormone Refractory Prostate Cancer 65 refractory AML 65 Prodarsan 65 PGL# 65 haematologic malignancies 65 generation purine nucleoside 65 unresectable liver cancer 65 BrachySil ™ 65 essential thrombocythemia ET 65 BARACLUDE ® 65 deCODE ProstateCancer TM 65 AVASTIN 65 RCW breast cancer 65 resectable 65 Tasimelteon 65 refractory chronic lymphocytic 65 gastrointestinal mucositis 65 PANVAC VF 65 Metastatic Colorectal Cancer 65 Chronic Sinusitis 65 Quinamed 65 Paraplatin ® 65 vandetanib 65 QuadraSphere 65 NSCLC tumors 65 rALLy clinical trial 65 Archexin 65 Methylnaltrexone 65 Teriflunomide 65 PROCRIT ® 65 Acute Ischemic Stroke 65 LUMINATE 65 Sorafenib 65 benign prostatic hypertrophy 65 keloid scarring 65 familial amyloidotic polyneuropathy FAP 65 Myelodysplastic Syndromes 65 Rheumatoid Arthritis RA 65 prostate cancer CRPC 65 postoperative atrial fibrillation 65 Cinquil 65 microsphere therapy 65 Crizotinib 65 chronic myeloid 65 Pertuzumab 65 Squamous Cell 65 PCNSL 65 cinacalcet 65 Abiraterone 65 Castration Resistant Prostate Cancer 65 teriflunomide 65 Phase IIIb study 65 oral FTY# 65 radioiodine therapy 65 Sentinel node biopsy 65 Vidaza ® 65 thetreatment 65 myocardial infarction ventricular fibrillation 65 eritoran 65 Phase #/#a trial 65 Tamibarotene 65 dasatinib Sprycel 65 TNFerade TM 65 Renal Impairment 65 Adult Stem Cell Therapy 65 QTc prolongation 65 colorectal carcinoma 65 Esophagitis 65 leiomyomas 65 DU #b 65 refractory angina 65 intra abdominal abscess 65 FUSILEV enhances 65 Friedreich Ataxia FRDA 65 lucinactant 65 cerebral vasospasm 65 malignant neoplasm 65 Prospective Randomized 65 Phase IIb clinical trials 65 HGS ETR1 mapatumumab 65 PEG SN# 65 UPLYSO 65 Phase 1b clinical trials 65 Bendamustine 65 INCB# [003] 65 Tyrosine Kinase Inhibitors 65 Pulmonary Arterial Hypertension PAH 65 interstitial cystitis IC 65 Acute Radiation Syndrome ARS 65 osteolytic bone disease 65 dirucotide 65 Benign Prostatic Hyperplasia 65 sapacitabine CYC# 65 Diabetic Foot Ulcer 65 peritoneal cancer 65 CINTREDEKIN BESUDOTOX 65 TNF Tumor Necrosis Factor 65 Warfarin Coumadin 65 APTIVUS r 65 Critical Limb Ischemia CLI 65 candidates Azedra TM 65 renal denervation 65 Ischemic 65 bladder cancers 65 Lilly Gemzar 65 OvaRex ® MAb 65 hepatitis C HCV 65 refractory NSCLC 65 Squalamine 65 Aplidin 65 fosbretabulin 65 lung pancreatic 65 hormone refractory 65 Genasense ® 65 Gleevec imatinib 65 miglustat 65 relapsing multiple sclerosis 65 Annamycin 65 Romiplostim 65 HGS ETR1 65 primary immunodeficiency PI 65 rFVIIa 65 Virulizin ® 65 Tumor Response 65 malignant polyps 65 SPRYCEL ® 65 FluCAM arm 65 Telatinib 65 juvenile idiopathic arthritis 65 defibrotide 65 immunomodulatory therapy 65 Triapine R 65 colorectal cancer CRC 65 cytotoxic therapy 65 ovarian lung 65 haematological cancers 65 pulmonary metastasis 65 Chemoradiation 65 Afatinib 65 Sezary syndrome 65 phase III isavuconazole 65 HNSCC 65 Basal cell 65 advanced metastatic renal 65 PROCHYMAL 65 clevidipine 65 Exherin TM 65 trial evaluating PRX# 65 treat benign prostatic 65 completely resected 65 hematological malignancy 65 Evoltra ® 65 PREZISTA r 65 Aurora Kinase 65 delivers fluocinolone acetonide FA 65 EUS FNA 65 hematopoietic cancers 65 SinuNase TM 65 catheter occlusion 65 Sapacitabine 65 paclitaxel Taxol ® 65 mutated KRAS gene 65 KRAS mutations occur 65 deferiprone 65 ximelagatran 65 ORENCIA R 65 Dupuytren Disease 65 Fludara 65 Pulmonary Arterial Hypertension 65 biliary stones 65 Meets Primary Endpoint 65 CR# vcMMAE 65 Chronic Myeloid Leukemia 65 Tigecycline 65 Cleviprex TM clevidipine 64 taxane chemotherapy 64 angiogenesis inhibitor 64 Radical prostatectomy 64 Actimmune ® 64 ZACTIMA TM ZD# 64 Nesiritide 64 cutaneous melanoma 64 GAMMAGARD 64 histological subtype 64 BioNumerik 64 heterozygous FH 64 skeletal metastases 64 pseudobulbar affect PBA 64 docetaxel Taxotere R 64 oral dual endothelin 64 ELACYT 64 Ophena 64 #D#C# 64 Gastric Cancer 64 advanced metastatic prostate 64 Retreatment 64 hypophosphatasia 64 medullary thyroid cancer 64 Infusion Reactions Severe 64 bardoxolone methyl 64 ixabepilone 64 Catena ® 64 EVIZON TM 64 unresectable locally advanced 64 Sipuleucel T 64 bevacizumab Avastin 64 glioblastoma tumors 64 intraductal 64 Diffuse Large B 64 TELCYTA 64 DCVax Brain 64 ZYVOX 64 MKC# MKC# PP 64 ACE Inhibitors 64 enzastaurin 64 radiofrequency ablation RFA 64 lomitapide 64 Aggrastat ® tirofiban hydrochloride 64 severe oral mucositis 64 cytoreductive surgery 64 cisplatin chemotherapy 64 Chronic Heart Failure 64 renal flares 64 5 fluorouracil leucovorin 64 metaglidasen 64 Prodarsan R 64 nucleoside analog 64 chronic eosinophilic leukemia 64 refractory anaplastic astrocytoma 64 gastrointestinal GI motility disorders 64 ADPKD 64 allogeneic bone marrow 64 Phase 2b Clinical Trial 64 symptomatic BPH 64 Pegloticase 64 Electronic Brachytherapy System 64 SIR Spheres 64 Dialysis Outcomes 64 metastatic liver 64 chronic HBV 64 targeted radiotherapeutic 64 Ceflatonin 64 FDG PET imaging 64 EndoTAG TM -1 64 patientswith 64 Acute Myelogenous Leukemia AML 64 leukemia APL 64 treating cancerous tumors 64 Telbivudine 64 sunitinib malate 64 paclitaxel Taxol R 64 Insegia 64 HBeAg negative 64 Minimally Invasive Procedure 64 Sanvar R 64 Mitoxantrone 64 IV metastatic melanoma 64 gastric adenocarcinoma 64 essential thrombocythemia 64 GTC recombinant human 64 Cetrorelix 64 serum phosphorous 64 mapatumumab 64 XYOTAX TM 64 SUPPRELIN R LA 64 gastrointestinal malignancies 64 axitinib 64 achieved CCyR 64 GnRH agonist 64 recurrent malignant glioma 64 Occlusive Disease 64 INTEGRILIN R 64 de novo kidney transplant 64 hormone refractory metastatic prostate 64 castrate resistant prostate cancer 64 MEK inhibitor RDEA# 64 photodynamic treatment 64 dexanabinol 64 osteoporotic compression fractures 64 mycosis fungoides 64 recurrent ovarian cancer 64 LymphoStat B belimumab 64 Brentuximab Vedotin SGN 64 pheochromocytoma 64 preoperative chemotherapy 64 BARACLUDE R 64 CRVO 64 HER2 positivity 64 denileukin diftitox 64 CMV disease 64 relapsed ovarian cancer 64 Actemra tocilizumab 64 Myocet 64 alkylating agent 64 chemotherapeutic regimen 64 Cell Lymphoma 64 ONCONASE R 64 decompensated liver disease 64 arthritis PsA 64 refractory Hodgkin 64 PROSTVAC ® 64 Acute Decompensated Heart Failure 64 modified glutathione analog 64 venous blood clots 64 BAY #-# 64 Chronic HCV 64 pleural mesothelioma 64 BEXXAR 64 esophageal gastric 64 Troxatyl 64 HBV infections 64 Irinotecan 64 biliary tract 64 Gleevec imatinib mesylate 64 Ribavirin causes 64 histologic subtype 64 Diabetic Macular Edema DME 64 Apaziquone 64 tramiprosate Alzhemed TM 64 transplantation HSCT 64 GSK# [001] 64 Li Fraumeni Syndrome 64 Lymphocytic 64 nodal metastasis 64 icatibant 64 TNF antagonist 64 OncoVex 64 intra arterial chemotherapy 64 peritumoral brain edema 64 ankylosing spondylitis AS 64 NMIBC 64 glufosfamide 64 NATRECOR R 64 antiangiogenic agent 64 tumor necrosis 64 Overactive Bladder 64 hepatocellular carcinoma 64 intravenous methylnaltrexone 64 Thromboembolism 64 corticosteroid dexamethasone 64 LE DT 64 palifermin 64 AKT inhibitor 64 Allovectin 7 ® 64 Acute myeloid leukemia 64 cutaneous T 64 unresectable 64 FVIIa 64 acyclovir Lauriad R 64 post operative ileus 64 sodium thiosulfate STS 64 TheraSphere 64 DCVax ® Brain 64 Panzem 64 HER2 expression 64 OvaRex R 64 DCVax R 64 prostate cancer PCa 64 Egrifta 64 noninfectious uveitis 64 neuroendocrine carcinoma 64 neovascular diseases 64 Hepatotoxicity 64 ORENCIA ® 64 sitaxsentan 64 nasopharyngeal carcinoma 64 Gliomas 64 Endometrial 64 VAPRISOL 64 Heart Transplant Recipients 64 Talabostat 64 PI3K/Akt pathway inhibitor 64 KRAS mutation 64 HuLuc# 64 dasatinib Sprycel ® 64 HoFH 64 Phase IIa trials 64 MyVax ® 64 evaluating mipomersen 64 Plicera 64 candidate CRLX# 64 herpes zoster shingles 64 rindopepimut 64 HDAC Inhibitor 64 postoperative pathology 64 velafermin 64 INSPIRE Trial Phase III 64 Alocrest 64 Carcinoma 64 HER2 Positive Breast Cancer 64 brivaracetam 64 refractory ovarian cancer 64 Tectin TM 64 membranous nephropathy 64 ALN TTR# 64 Chronic Myelogenous Leukemia 64 Coronary Artery Bypass Graft 64 Achieves Primary Endpoint 64 CINQUIL 64 lymphomas leukemias 64 VFEND 64 Aurexis 64 plus dacarbazine 64 Perforomist ™ Inhalation Solution 64 Neoadjuvant 64 cardio renal 64 Colon polyps 64 treatment naive genotype 64 Sutent sunitinib 64 multicenter randomized placebo controlled 64 COREG 64 paragangliomas 64 SCIg 64 relapsed multiple myeloma 64 IMC #B 64 Omacetaxine 64 Acute Coronary Syndromes ACS 64 transarterial 64 Chronic myeloid leukemia 64 Benign prostatic hyperplasia BPH 64 chronic idiopathic thrombocytopenic purpura 64 Silodosin 64 bevacizumab Avastin ® 64 bladder ovarian 64 intravascular hemolysis 64 personalized cellular immunotherapy 64 metastatic androgen independent 64 LEP ETU 64 Recurrences 64 biomarker identification 64 Liprotamase 64 Acute Myeloid Leukaemia AML 64 tumor histology 64 glioblastoma multiforme GBM 64 CMV infections 64 relapsed refractory multiple myeloma 64 post thrombotic syndrome 64 Venous thromboembolism 64 panitumumab Vectibix 64 metastatic HRPC 64 Randomized Phase II 64 PD LID 64 fibromyalgia syndrome 64 Curaxin CBLC# 64 Zybrestat 64 severe hypercholesterolemia 64 abacavir Ziagen 64 fallopian tube cancers 64 lymphocytic leukemia 64 Initiate Clinical Trial 64 curative therapy 64 EDEMA3 64 Edge STudy 64 brand ciclesonide HFA 64 breast carcinoma 64 prostate cancer metastases 64 transplantation HCT 64 corticosteroid therapy 64 elotuzumab 64 Juvenile Idiopathic Arthritis 64 resistant hormone refractory 64 zileuton IV 64 intestinal metaplasia 64 Myelofibrosis 64 anticancer compound 64 DIPG 64 bortezomib Velcade 64 anti angiogenic agents 64 PKC# 64 CTAP# 64 non hodgkin lymphoma 64 regorafenib 64 TYGACIL 64 anticancer therapy 64 metformin accumulation 64 Androgen Deprivation Therapy 64 Platinol ® cisplatin 64 curative resection 64 ganetespib 64 MCSP respectively 64 Voreloxin 64 Glioma 64 alpha interferons 64 Deferiprone 64 SNT-MC#/idebenone 64 adjuvant colon cancer 64 lumiliximab 64 Solazed TM 64 Relapsed Refractory 64 Certican 64 MyVax personalized immunotherapy 64 SJIA 64 GED aPC 64 NovoTTF 64 mucinous 64 tamoxifen Nolvadex ® 64 OZURDEX ® 64 malignant growths 64 R Saizen R 64 IMiDs ® compound 64 neurogenic bladder 64 plasma kallikrein inhibitor 64 Lovaxin C 64 ThermoDox ® clinical 64 MKC# MT 64 GBM tumors 64 homozygous familial hypercholesterolemia 64 BCIRG 64 retinal vein occlusion induced 64 Chronic Lymphocytic Leukemia 64 treat chronic sinusitis 64 Tyrosine Kinase Inhibitor 64 mTOR inhibitors 64 stem cell transplantations 64 Trofex 64 HuCNS SC ® 64 Aldara Cream 64 Zavesca R 64 Cholangiocarcinoma